Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| P01CA049605 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
| National Institutes of Health (NIH) | NIH |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.
The purpose of this study is to acquire critical tissue and biological samples that can be evaluated to elucidate underlying mechanisms of disease control, transplant related complications and overall outcomes
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Graft recipients and donors |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| collection and storage of tissue samples for research | Procedure | Tissue samples include blood draws for the donor and recipient. A bone marrow sample may be obtained from the recipient. If the recipient undergoes a tissue biopsy for clinical reasons, a small fraction may be removed for research purposes. A small fraction of the donor graft may be removed at the time of collection for research. |
| Measure | Description | Time Frame |
|---|---|---|
| Identify and characterize proteins and genes that may contribute to the development and progression of cancer. | blood sample is collected prior transplant, periodically during the first three months and then indefinately at follow up |
Not provided
Not provided
Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate
Exclusion Criteria:- Subject does not agree to participate
Not provided
Not provided
All hematopoietic cell transplant recipients and donors who agree to participate
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Miklos | Stanford University | Principal Investigator |
| Robert S Negrin | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007938 | Leukemia |
| D008223 | Lymphoma |
| D006402 | Hematologic Diseases |
| ID | Term |
|---|---|
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006425 | Hemic and Lymphatic Diseases |
| D008232 | Lymphoproliferative Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Tissue samples will be obtained from subjects undergoing transplantation or donors providing the graft.
|
| D008206 | Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |